Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

British Journal of Cancer (36)
Oncogene (1)
Nature Communications (1)
Nature Reviews Clinical Oncology (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (38)
Comments & Opinion (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biomarkers
Cancer
Cell biology
Computational biology and bioinformatics
Diseases
Genetics
Health care
Immunology
Medical research
Oncology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–39 of 39 results

Advanced filters: Author: S Pecorelli Clear advanced filters

A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion

S Bendifallah
G Canlorbe
M Ballester
ResearchOpen Access08 May 2014
British Journal of Cancer

Volume: 110, P: 2640-2646
Protein expression patterns in primary carcinoma of the vagina

K Hellman
A A Alaiya
G Auer
ResearchOpen Access15 Jun 2004
British Journal of Cancer

Volume: 91, P: 319-326
Which second-line treatment regimen should be used following relapse of platinum-sensitive ovarian cancer?

Sergio Pecorelli
Franco Odicino
Comments & Opinion03 Apr 2007
Nature Clinical Practice Oncology

Volume: 4, P: 340-341
Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas

I S Haldorsen
I Stefansson
H B Salvesen
ResearchOpen Access31 Oct 2013
British Journal of Cancer

Volume: 110, P: 107-114
Just how accurate are the major risk stratification systems for early-stage endometrial cancer?

S Bendifallah
G Canlorbe
M Ballester
ResearchOpen Access12 Feb 2015
British Journal of Cancer

Volume: 112, P: 793-801
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials

K Aabo
M Adams
BY Yeap
Research01 Dec 1998
British Journal of Cancer

Volume: 78, P: 1479-1487
Nomogram prediction for overall survival of patients diagnosed with cervical cancer

S Polterauer
C Grimm
G Heinze
ResearchOpen Access07 Aug 2012
British Journal of Cancer

Volume: 107, P: 918-924
Management of borderline change in endocervical cells: a more dependable approach

S Kodiathodi
S Chattopadhyay
P Franks
ResearchOpen Access26 Jun 2014
British Journal of Cancer

Volume: 111, P: 851-857
MtDNA mutagenesis impairs elimination of mitochondria during erythroid maturation leading to enhanced erythrocyte destruction

Accumulation of mitochondrial DNA (mtDNA) mutations is linked to severe anaemia by an unknown mechanism. Here the authors show that excessive mtDNA mutations impair mitochondrial expulsion during erythropoiesis leading to augmented erythrocyte clearance and anaemia in mice and humans.

K.J. Ahlqvist
S. Leoncini
A. Suomalainen
Research09 Mar 2015
Nature Communications

Volume: 6, P: 1-11
A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancer

P Pronzato
G Bertelli
F Vaira
Research01 Jun 1996
British Journal of Cancer

Volume: 73, P: 1425-1427
Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients

Ingvild L Tangen
Reidun K Kopperud
Camilla Krakstad
ResearchOpen Access27 Jul 2017
British Journal of Cancer

Volume: 117, P: 840-847
Prognostic discrimination of subgrouping node-positive endometrioid uterine cancer: location vs nodal extent

D S Kapp
T K Kiet
J K Chan
ResearchOpen Access13 Sept 2011
British Journal of Cancer

Volume: 105, P: 1137-1143
Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group

Lobna Ouldamer
Sofiane Bendifallah
Marcos Ballester
ResearchOpen Access08 Nov 2016
British Journal of Cancer

Volume: 115, P: 1296-1303
The relationship between tumour glutathione concentration, glutathione S-transferase isoenzyme expression and response to single agent carboplatin in epithelial ovarian cancer patients

S Ghazal-Aswad
L Hogarth
DR Newell
Research01 Aug 1996
British Journal of Cancer

Volume: 74, P: 468-473
Prognostic factors in advanced epithelial ovarian cancer

S Marsoni
V Torri
C Mangioni
Research01 Sept 1990
British Journal of Cancer

Volume: 62, P: 444-450
Spindle cell morphology is related to poor prognosis in vulvar squamous cell carcinoma

M D Trietsch
A A W Peters
G J Fleuren
ResearchOpen Access24 Sept 2013
British Journal of Cancer

Volume: 109, P: 2259-2265
MAGE, BAGE and GAGE: tumour antigen expression in benign and malignant ovarian tissue

AM Gillespie
S Rodgers
AK Murray
Research01 Sept 1998
British Journal of Cancer

Volume: 78, P: 816-821
A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma

TJ Perren
E Wiltshaw
PR Blake
Research01 Dec 1993
British Journal of Cancer

Volume: 68, P: 1190-1194
Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the ‘Mario Negri’ Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group

A Buda
I Floriani
C Mangioni
ResearchOpen Access20 Apr 2004
British Journal of Cancer

Volume: 90, P: 2112-2117
Long-term follow-up of patients with advanced ovarian cancer treated in randomised clinical trials

J Warwick
S Kehoe
KK Chan
Research01 Dec 1995
British Journal of Cancer

Volume: 72, P: 1513-1517
Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary

G Mangili
J Ottolina
D Lorusso
ResearchOpen Access11 Jun 2013
British Journal of Cancer

Volume: 109, P: 29-34
Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)

N Katsumata
H Yoshikawa
T Kamura
ResearchOpen Access02 May 2013
British Journal of Cancer

Volume: 108, P: 1957-1963
Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer

P A Vasey
R Atkinson
S B Kaye
ResearchOpen Access16 Jan 2001
British Journal of Cancer

Volume: 84, P: 170-178
Diagnosis of persistent ovarian carcinoma with three-step immunoscintigraphy

P Magnani
F Fazio
G Paganelli
ResearchOpen Access07 Jan 2000
British Journal of Cancer

Volume: 82, P: 616-620
HER2 expression patterns in paired primary and metastatic endometrial cancer lesions

Mari Kyllesø Halle
Ingvild Løberg Tangen
Camilla Krakstad
ResearchOpen Access23 Nov 2017
British Journal of Cancer

Volume: 118, P: 378-387
Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas

E Bignotti
A Ravaggi
A D Santin
ResearchOpen Access05 Aug 2008
British Journal of Cancer

Volume: 99, P: 768-773
Induction of tumour-specific CD8⁺ cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer

A D Santin
S Bellone
M J Cannon
Research25 Jan 2002
British Journal of Cancer

Volume: 86, P: 151-157
Preoperative nomogram for the identification of lymph node metastasis in early cervical cancer

D-Y Kim
S-H Shim
J-H Nam
ResearchOpen Access14 Nov 2013
British Journal of Cancer

Volume: 110, P: 34-41
Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy

A D Santin
F Zhan
S Pecorelli
ResearchOpen Access22 Mar 2005
British Journal of Cancer

Volume: 92, P: 1561-1573
Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy

S Bellone
R Tassi
A D Santin
ResearchOpen Access27 Jun 2013
British Journal of Cancer

Volume: 109, P: 462-471
Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling

A D Santin
F Zhan
S Pecorelli
ResearchOpen Access27 Apr 2004
British Journal of Cancer

Volume: 90, P: 1814-1824
Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy

S Bellone
D Roque
A D Santin
ResearchOpen Access24 Apr 2012
British Journal of Cancer

Volume: 106, P: 1543-1550
In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma

K El-Sahwi
S Bellone
A D Santin
ResearchOpen Access17 Nov 2009
British Journal of Cancer

Volume: 102, P: 134-143
Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab

P Todeschini
E Cocco
A D Santin
ResearchOpen Access13 Sept 2011
British Journal of Cancer

Volume: 105, P: 1176-1182
Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer

E Cocco
S Bellone
A D Santin
ResearchOpen Access16 Jun 2009
British Journal of Cancer

Volume: 101, P: 335-341
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

E Bignotti
M Ragnoli
A Ravaggi
ResearchOpen Access05 Apr 2011
British Journal of Cancer

Volume: 104, P: 1418-1425
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

E S Ratner
F K Keane
J B Weidhaas
Research05 Dec 2011
Oncogene

Volume: 31, P: 4559-4566
Kinase-driven metabolic signalling as a predictor of response to carboplatin–paclitaxel adjuvant treatment in advanced ovarian cancers

Maria Isabella Sereni
Elisa Baldelli
Mariaelena Pierobon
ResearchOpen Access29 Jun 2017
British Journal of Cancer

Volume: 117, P: 494-502
hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma

E Cocco
Z Hu
A D Santin
ResearchOpen Access10 Aug 2010
British Journal of Cancer

Volume: 103, P: 812-819

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

© 2025 Springer Nature Limited